ASTEPRO ALLERGY FDA approval date

The FDA approved ASTEPRO ALLERGY on 17 Jun 2021.

FDA approval date
17 Jun 2021

Drug identity has not yet been verified against registry records

Also recorded as AZELASTINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-06-17DayASTEPRO ALLERGYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213872", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["ASTEPRO ALLERGY", "CHILDREN'S ASTEPRO ALLERGY"], "active_ingredients": ["AZELASTINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210617", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026